Fny Investment Advisers, LLC Eli Lilly & CO Transaction History

Fny Investment Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$772.14 - $960.02 $3.26 Million - $4.06 Million	4,226 New	4,226 $3.74 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $95,344 - $127,557	-161 Reduced 44.6%	200 $155,000
Q4 2023 Jan 12, 2024	BUY	$525.19 - $619.13 $189,593 - $223,505	361 New	361 $210,000
Q3 2022 Oct 19, 2022	BUY	$296.48 - $337.87 $53,662 - $61,154	181 New	181 $58,000
Q1 2019 Apr 17, 2019	SELL	$111.31 - $131.02 $11,576 - $13,626	-104 Closed	0 $0
Q4 2018 Jan 22, 2019	SELL	$105.9 - $118.64 $51,785 - $58,014	-489 Reduced 82.46%	104 $12,000
Q3 2018 Oct 29, 2018	BUY	$85.86 - $107.31 $39,495 - $49,362	460 Added 345.86%	593 $63,000
Q2 2018 Jul 18, 2018	BUY	$75.7 - $86.88 $10,068 - $11,555	133 New	133 $11,000

4,033

737M

8.26M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $746B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.